Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy
ncbi.nlm.nih.gov/pmc/articl...
"Results
During a median follow up of 2.95 years, 208 patients died, of which 169 died due to progressive prostate cancer. At baseline, the 5‐year CSS and OS rates were 65.5% and 58.2%, respectively. Conditional 5‐year net CSS and OS survival gradually increased for all the patients. In patients given a 5‐year survivorship, the conditional 5‐year net CSS and OS rates improved to 0.906 and 0.811, respectively. Only the extent of disease score (EOD) ≥2 remained a prognostic factor for CSS and OS up to 5 years; as survival time increased, other variables were no longer independent prognostic factors."
I was looking for a study that looked at the "conditional" survival (given you have survived x-number of years, what is the probability of surviving another y-years). This one caught my attention. Intuitively, the results make sense. I was hoping to see some quantitative analysis, and this report seems to be providing something reasonable (subject to the limitations clause). Its database does not include the combined ADT+Abi/Chemo cohort, but the results should be indicative.